Skip to main content

Table 2 Frequency of treatment toxicity

From: Association of genetic polymorphism of NUDT15, TPMT and ITPA gene in the toxicity and efficacy of azathioprine-based regimen in Egyptian inflammatory bowel disease patients

Parameter

IBD N = 150

Toxicity N, %

113 (75.3%)

Fever N, %

21 (14.0%)

Hypersensitivity and Rash N, %

16 (10.7%)

Hemolysis N, %

9 (6.0%)

Febrile neutropenia N, %

3 (2.0%)

Myelosuppression N, %

38 (25.3%)

GIT intolerance N, %

13 (8.7%)

Flu-like symptoms N, %

27 (18.0%)

skin disorders N, %

22 (14.7%)

Anemia N, %

113 (75.3%)

Leucopenia N, %

21 (14.0%)